chr13-48367493-G-A
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_000321.3(RB1):c.940-1G>A variant causes a splice acceptor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000321.3 splice_acceptor, intron
Scores
Clinical Significance
Conservation
Publications
- hereditary retinoblastomaInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics
- retinoblastomaInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- melanomaInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| RB1 | NM_000321.3 | c.940-1G>A | splice_acceptor_variant, intron_variant | Intron 9 of 26 | ENST00000267163.6 | NP_000312.2 | ||
| RB1 | NM_001407165.1 | c.940-1G>A | splice_acceptor_variant, intron_variant | Intron 9 of 26 | NP_001394094.1 | |||
| RB1 | NM_001407166.1 | c.940-1G>A | splice_acceptor_variant, intron_variant | Intron 9 of 16 | NP_001394095.1 | |||
| LOC112268118 | XR_002957522.2 | n.122-2517C>T | intron_variant | Intron 2 of 2 | 
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD4 exome Cov.: 30 
GnomAD4 genome  
ClinVar
Submissions by phenotype
Retinoblastoma    Pathogenic:2 
Case and Pedigree Information: BILATERAL CASES:1, UNILATERAL CASES:0, TOTAL CASES:1, PEDIGREES:1. ACMG Codes Applied:PVS1, PM2 -
This sequence change affects an acceptor splice site in intron 9 of the RB1 gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in RB1 are known to be pathogenic (PMID: 17096365). This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with bilateral retinoblastoma (PMID: 27582626, 33456302; Invitae). ClinVar contains an entry for this variant (Variation ID: 428678). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. -
Hereditary cancer-predisposing syndrome    Pathogenic:1 
The c.940-1G>A intronic pathogenic mutation results from a G to A substitution one nucleotide upstream from coding exon 10 of the RB1 gene. This mutation has been reported in multiple patients with unilateral and bilateral retinoblastoma (Singh J et al. Mol. Vis., 2016 Aug;22:1036-47; Ambry internal data). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). In silico splice site analysis predicts that this alteration will weaken the native splice acceptor site. Alterations that disrupt the canonical splice site are expected to cause aberrant splicing, resulting in an abnormal protein or a transcript that is subject to nonsense-mediated mRNA decay. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at